The International Committee of Medical Journal Editors recommends the prospective registration of interventional clinical trials. We aimed to assess the compliance with these guidelines for manuscripts submitted to and published by a single anaesthetic journal. We examined the rates of prospective trial registration, the incidence of discrepancies in primary outcome measure(s) and sample sizes, and the citation metrics of all randomised controlled trials published in Anaesthesia over a 3-year period (2014)(2015)(2016). Of the 422 randomised controlled trials submitted during the study period, 115 (27.3%) were accepted for publication, of which 90 (78.3%) were patient studies, with the remaining 25 comprising manikin, simulation, volunteer, bench, cadaver and other non-patient intervention studies. Of the accepted patient studies, 64 (71.1%) were prospectively registered with a clinical trials registry, 20 (22.2%) were not registered and 6 (6.7%) were retrospectively registered after manuscript submission. There was no difference in the frequency of registration between accepted and rejected manuscripts (77.8% vs. 84.5%, respectively, p = 0.143). The median (IQR [range]) time from registration of accepted manuscripts to journal submission was 701 (331-1341 [99-2436]) days. There was no correlation between number of patients recruited to a study and time to submission. Fifty-two (81.3%) of the prospectively registered studies reported the same primary outcomes in both registration and submission, and 34 (53.1%) studies were published with the same powered sample size as that described in the registry. Eleven (12.2%) studies recruited more patients and 19 (21.1%) recruited fewer patients than described in the registration protocol. There was no difference in the median ( 
Introduction
In 2004, the International Committee of Medical Journal Editors (ICMJE) recommended the prospective registration of interventional clinical trials involving human subjects in order to reduce publication bias and selective reporting of positive results [1] . In the USA, a recently revised Food and Drug Administration Amendments Act makes the registration and reporting of results of controlled trials a legal requirement to be adhered to by clinical trial sponsors and designated principle investigators [2] . Failure of responsible parties to comply with these regulations can result in monetary penalties, withholding of grant subsidies or even criminal proceedings [2] . Despite this, only 29-36% of published studies in anaesthetic-related journals are prospectively registered on a publicly accessible database [3] [4] [5] . There is also inconsistency in outcome reporting, with 25-48% of studies having discrepancies in primary outcome(s) [3] [4] [5] and 7-55% alterations in the sample size [3, 5] between the registered and published versions. However, these data are from studies that were undertaken before the majority of journals began to enforce prospective trial registration as a requirement for publication [6] [7] [8] [9] . Recent analyses in non-anaesthetic journals have suggested improvements in registration and reporting practice [9] [10] [11] [12] .
We wished to explore the methodological rigour of randomised patient studies published in a single anaesthetic journal over a 3-year period. We hypothesised that there would be high, or even universal compliance, with prospective trial registration requirements, and that this would be reflected in higher acceptance rates and study citation metrics.
Methods
All manuscript files and author declaration forms submitted to Anaesthesia are allocated a unique manuscript reference number and stored in chronological order on the dedicated journal drive hosted by the Association of Anaesthetists of Great Britain and Ireland (AAGBI) server. From the point of submission, manuscript details are recorded on a database and updated as appropriate throughout the reviewing process. Completed author declaration forms for manuscripts describing those randomised controlled trials (RCTs) that are registered include the name of the trial registry and trial registration number. Data from all RCT submissions to the journal, whether accepted for publication or rejected, were sought. Study documents were collected by one author (SA) and study selection and data extraction were conducted by three authors independently (KE, MDW, CRB).
All articles that were submitted between 1 January 2014 and 31 December 2016 were screened. Published studies were then examined by title, abstract and fulltext screening of each edition of Anaesthesia from January 2014 to December 2016 (volumes 69-71). Original articles that were randomised patient studies generating quantitative data and comparing two or more interventions were included.
Simulation, manikin, volunteer, cadaveric, animal and other non-patient studies were excluded, as guidelines for these studies do not explicitly mandate prospective trial registration [13] [14] [15] [16] . Author declaration forms from published studies meeting inclusion criteria were located by matching the manuscript digital object identifier (DOI) and respective manuscript reference number, and forms were then examined.
Relevant data extracted from either the final manuscript or author declaration form included country of origin, clinical trial registration information, and primary or secondary outcome measure(s). Clinical trial registration details comprised primary registry, trial identifying number, date of registration, date of subject recruitment and date of manuscript submission. Outcome data extracted included the defined primary outcome(s) and number of patients recruited based on the published power analysis.
If trial registration information was provided in either the manuscript or the author declaration form, these registers were accessed and study data extracted. If no registration information was provided, a manual search was conducted using available study information, including study title, authors, country, city, institution, clinical comparators or outcomes. Databases searched comprised registers from the country of study origin, as well as the following commonly used inter- 
Results
Of the 422 RCTs submitted to Anaesthesia during the study period, 373 met the study inclusion criteria as being patient studies. Of these, 90 (24.1%) were accepted for publication and thus relevant to analysis, and 283 (75.9%) were not accepted for publication in Anaesthesia and therefore not relevant to further analysis ( Fig. 1 ). The countries of origin for the published studies are shown in Table 1 . The overall acceptance rate was 27.3% (43.5% in 2014, 26.7% in 2015 and 25.9% in 2016). With regard to trial registration, 64 out of 90 (71.1%) of the accepted studies were prospectively registered in a clinical trials database, and 6 out of 90 (6.7%) were retrospectively registered after manuscript submission, and 20 were unregistered (22.2%). This was similar for the rejected studies, with 239 out of 283 (84.5%) being registered (p = 0.143). A total of 9293 patients were recruited into randomised studies published in Anaesthesia, of which 7175 were recruited in prospectively registered studies (n = 64 papers), 411 in retrospectively registered studies (n = 6 papers) and 1707 in studies that were not registered (n = 20 papers). Many of the rejected studies are known to be published elsewhere [17] .
Of the 64 randomised patient studies that were prospectively registered, the median (IQR [range]) time from registration to journal submission was 701 (331-1341 [99-2436]) days. There was no correlation between the number of patients recruited to a study and time between registration and submission, q = 0.014 ( Fig. 2; p = 0.913) .
Of the trials registered before manuscript submission, subject recruitment start dates were available for 46 out of 64 (71.9%) studies, 21 of which were prospectively registered before commencing patient recruitment, and 25 of which were registered after starting patient recruitment ( Table 2) .
Of the prospectively registered studies, 52 out of 64 (81.3%) reported the same primary outcomes in both the trial registry and submitted manuscript. Of the 12 studies with disparities between registered and published primary outcomes, eight studies reported these outcomes as secondary outcomes, whereas in four studies the definitions of primary and/or secondary outcomes were unclear. One study published a statistically insignificant result for a secondary outcome that was initially registered as a primary outcome. With respect to sample size, 34 out of 64 (53.1%) of the prospectively registered studies were published with the same powered sample size as that described at registration; 11 studies recruited more, and 19 recruited fewer patients than that described in the registered sample size. 
Discussion
Although the acceptance rate has decreased over the study period, our data do not support our primary hypothesis, as we found that trial registration has no influence on whether or not a manuscript is accepted for publication in Anaesthesia, and has little impact on citation metrics.
There are a number of reasons that have been proposed to support prospective clinical trial registration as being best practice [18] . Registration provides a record of all studies, highlighting those registered studies which remain unpublished. This is particularly relevant to studies with equivocal or negative results, with one of the purported benefits of trial registration being to potentially reduce publication bias [19] . Ross et al. [20] found that 46% of a sample of studies registered at ClinicalTrials.gov between December 1999 and December 2005 had actually been published by 2009. Trial registration can also identify 'salami slicing' multiple publications from the same dataset [21] . Prospective clinical trial registration also provides a record of the stated primary outcome, therefore possibly negating selective outcome reporting and any temptation to alter it after data analysis [22, 23] . The latter is important in the notion of 'hypothesis testing'; scientific studies should, ideally, be designed in order to test a hypothesis and therefore have a primary research question focussed on a primary end-point defined a priori. To change the end-point is, in effect, to change the question being asked [24] . Similarly, sample size determination and registration is dependent on this primary outcome. Challenges recruiting sufficient study subjects might lead to modification of sample size calculations and thus study power, which would be apparent when comparing published with registered sample sizes. The principle of trial registration has authoritative support. The World Health Organization (WHO) recommends trial registration and lists 20 items (such as dates of registration, trial identification numbers, interventions investigated, sample sizes and primary and secondary outcomes) that should be completed [25] . The ICMJE has a policy for Uniform Requirements for Manuscripts which states that all authors reporting a clinical trial should register that trial in a registry [26] and clearly identify the trial registry within the manuscript, which Anaesthesia now does. They also expect registration to occur before enrolling the first participant, that is, prospective registration. The UK National Health Service research ethics committees go further and state that trial registration should be a requirement before ethical approval is sought [27] .
In this context, Anaesthesia requests trial registration of authors, but does not strictly enforce it: reasons for not registering a study should be shared with the Time (days)
Patients recruited Figure 2 Scatter plot demonstrating the relationship between number of patients recruited to each study and the time in days from trial registration to submission in all prospectively registered randomised controlled patient trials published in Anaesthesia during the study period. Each dot represents a single trial.
Editor-in-Chief and clearly explained within the manuscript itself. We found that the registration rate was similar for trials that were rejected by the journal compared with those that were accepted. This suggests that the editorial team is not prejudiced against unregistered trials, but rather is committed to publishing studies that are original and of interest to readers, regardless of registration status. Our finding that only 71.1% of trials were registered prospectively is still higher than that of Myles [28] who found that only 54% of studies published in the British Journal of Anaesthesia in 2011 reported trial registration. Although prospective trial registration appears to have little impact on acceptance by Anaesthesia, articles accepted eventually have higher citability than those rejected but which then eventually go on to be published elsewhere [17] . The policy suggested by respective author guidance of other high-impact anaesthetic journals might vary from Anaesthesia [29] [30] [31] . Thus, the primary determinant of the academic outcome from a clinical study may relate to study 'quality', and this appears to be independent of registration status. Our results give a unique insight to several other aspects of the academic process. Selective reporting of outcomes, either by reporting only favourable outcomes as primary or by obscuring unfavourable outcomes [23] , has been demonstrated in up to 92% of studies in the top six anaesthesia journals (including Anaesthesia) [11] . The bias may lie with both authors and reviewers/editors, none of whom wish to publish negative outcomes. Our data are consistent with these reports, as the primary outcome that appeared in the final manuscript was different from that registered in 12 studies (18.8%), seven of which the primary outcome was actually recorded as a secondary outcome. This result suggests that applying a blanket rule of prospective clinical trial registration does not eliminate the risk of selective reporting. Instead, assessing the merit and quality of each study individually might more effectively filter out selective reporting, as these are more likely to be studies with lower methodological quality. Our results suggest that this appears to be the case for Anaesthesia.
Abdulatif et al. [32] looked at 194 RCTs in the anaesthetic literature and found that original and replicated sample sizes were identical in just 68% of trials. Performing a power calculation enables researchers to determine the sample size required to detect a difference with an acceptable degree of statistical confidence, and a priori calculation is said to increase methodological quality [33] . These deficiencies in power reporting are well described throughout the literature [7, [33] [34] [35] . Our data showed that only 34 out of 64 (53.1%) studies were published with the same powered sample size as that registered, despite 71.1% of patient studies being prospectively registered. This suggests that the process of prospective trial registration does not inherently eliminate the erroneous practice of sample size adjustment.
The Consolidated Standards of Reporting Trials (CONSORT) statement aims to improve the reporting quality of RCTs [36] , with a 25-item checklist for reporting key items within manuscripts. Included in the checklist are trial registration details and sample [37] . This has increased to 63% in more recent analyses, and it is likely to continue in the same trajectory [38] . Folkes et al. found that, 58% of medical journals now follow the CONSORT guidelines [39] . However, the CONSORT guidance is merely a tool to improve the reporting of trials, rather than a means to improve methodological quality. At the point of completing the checklist, clinical trials have usually ended, and a failure of trial registration and inconsistency in outcomes and sample size calculation might already have taken place. Thus, adherence to the CONSORT statement principles per se might not improve trial registration, study quality or even citation metrics. Our study has several limitations. Only data for the last three years were analysed and during this time period the Editor-in-Chief and editorial board members changed, and this may have influenced the type and quality of submissions that were received and either accepted or rejected. Although the editorial board does not explicitly influence the type of manuscript submitted, we believe that authors are more likely to submit manuscripts to journals that have a track record of publishing similar types of studies to the one that they have completed. Another limitation of this study is that we decided to analyse the last three years only; Langford et al. [40] determined the quality of trial design and reported in the same journal over a 25-year period up until 2009. They found that the quality improved over time, and we believe that the present study demonstrates even greater improvement in trial quality over the last three years. We have only analysed one anaesthetic journal and this may not be representative of other anaesthetic or general medical journals. Another limitation is that we did not analyse registry sites in detail and therefore do not have a denominator to assess the proportion of trials that have been registered but not published. Although this was beyond the scope of our review, recent data suggest that half the clinical trials that are ethically approved remain unpublished [41] , and less than a third of all clinical trials are published in academic journals within two years of completion [42] .
In conclusion, we have demonstrated that, although it is encouraged as good practice, prospective trial registration does not mean that studies are more likely to be published in Anaesthesia. Randomised controlled trials that are prospectively registered are not cited more often than those that are retrospectively registered or unregistered. We have not found evidence that trial registration eliminates sample size modification or selective outcome reporting. The international recommendation for prospective trial registration does not appear to have been universally incorporated into anaesthetic-related research practice.
